102 related articles for article (PubMed ID: 30039745)
1. Analysis of conversion of Alzheimer's disease using a multi-state Markov model.
Zhang L; Lim CY; Maiti T; Li Y; Choi J; Bozoki A; Zhu DC; ;
Stat Methods Med Res; 2019 Sep; 28(9):2801-2819. PubMed ID: 30039745
[TBL] [Abstract][Full Text] [Related]
2. Multi-state Markov model in outcome of mild cognitive impairments among community elderly residents in Mainland China.
Yu HM; Yang SS; Gao JW; Zhou LY; Liang RF; Qu CY
Int Psychogeriatr; 2013 May; 25(5):797-804. PubMed ID: 23286508
[TBL] [Abstract][Full Text] [Related]
3. Bayesian hidden Markov models for delineating the pathology of Alzheimer's disease.
Kang K; Cai J; Song X; Zhu H
Stat Methods Med Res; 2019 Jul; 28(7):2112-2124. PubMed ID: 29278101
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Different Hypotheses Regarding the Spread of Alzheimer's Disease Using Markov Random Fields and Multimodal Imaging.
Dyrba M; Grothe MJ; Mohammadi A; Binder H; Kirste T; Teipel SJ;
J Alzheimers Dis; 2018; 65(3):731-746. PubMed ID: 28697557
[TBL] [Abstract][Full Text] [Related]
5. Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts.
Buckley RF; Mormino EC; Amariglio RE; Properzi MJ; Rabin JS; Lim YY; Papp KV; Jacobs HIL; Burnham S; Hanseeuw BJ; Doré V; Dobson A; Masters CL; Waller M; Rowe CC; Maruff P; Donohue MC; Rentz DM; Kirn D; Hedden T; Chhatwal J; Schultz AP; Johnson KA; Villemagne VL; Sperling RA; ; ;
Alzheimers Dement; 2018 Sep; 14(9):1193-1203. PubMed ID: 29803541
[TBL] [Abstract][Full Text] [Related]
6. Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study.
Kuusisto J; Koivisto K; Mykkänen L; Helkala EL; Vanhanen M; Hänninen T; Kervinen K; Kesäniemi YA; Riekkinen PJ; Laakso M
BMJ; 1997 Oct; 315(7115):1045-9. PubMed ID: 9366728
[TBL] [Abstract][Full Text] [Related]
7. Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer's disease in cognitively normal older adults with subjective memory complaints.
Cavedo E; Chiesa PA; Houot M; Ferretti MT; Grothe MJ; Teipel SJ; Lista S; Habert MO; Potier MC; Dubois B; Hampel H; ;
Alzheimers Dement; 2018 Sep; 14(9):1204-1215. PubMed ID: 30201102
[TBL] [Abstract][Full Text] [Related]
8. Use of neuroimaging to detect early brain changes in people at genetic risk for Alzheimer's disease.
Small GW
Adv Drug Deliv Rev; 2002 Dec; 54(12):1561-6. PubMed ID: 12453673
[TBL] [Abstract][Full Text] [Related]
9. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging.
Jobst KA; Barnetson LP; Shepstone BJ
Int Psychogeriatr; 1998 Sep; 10(3):271-302. PubMed ID: 9785148
[TBL] [Abstract][Full Text] [Related]
10. Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia.
Trzepacz PT; Yu P; Sun J; Schuh K; Case M; Witte MM; Hochstetler H; Hake A;
Neurobiol Aging; 2014 Jan; 35(1):143-51. PubMed ID: 23954175
[TBL] [Abstract][Full Text] [Related]
11. An improved model for disease progression in patients from the Alzheimer's disease neuroimaging initiative.
Samtani MN; Farnum M; Lobanov V; Yang E; Raghavan N; Dibernardo A; Narayan V;
J Clin Pharmacol; 2012 May; 52(5):629-44. PubMed ID: 21659625
[TBL] [Abstract][Full Text] [Related]
12. MRI-visible perivascular space location is associated with Alzheimer's disease independently of amyloid burden.
Banerjee G; Kim HJ; Fox Z; Jäger HR; Wilson D; Charidimou A; Na HK; Na DL; Seo SW; Werring DJ
Brain; 2017 Apr; 140(4):1107-1116. PubMed ID: 28335021
[TBL] [Abstract][Full Text] [Related]
13. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Löwe LC; Gaser C; Franke K;
PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
[TBL] [Abstract][Full Text] [Related]
14. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
[TBL] [Abstract][Full Text] [Related]
15. Neuroimaging basis in the conversion of aMCI patients with APOE-ε4 to AD: study protocol of a prospective diagnostic trial.
Chen GQ; Sheng C; Li YX; Yu Y; Wang XN; Sun Y; Li HY; Li XY; Xie YY; Han Y
BMC Neurol; 2016 May; 16():64. PubMed ID: 27176479
[TBL] [Abstract][Full Text] [Related]
16. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
Jobst KA; Barnetson LP; Shepstone BJ
Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
[TBL] [Abstract][Full Text] [Related]
17. Mild traumatic brain injury is associated with reduced cortical thickness in those at risk for Alzheimer's disease.
Hayes JP; Logue MW; Sadeh N; Spielberg JM; Verfaellie M; Hayes SM; Reagan A; Salat DH; Wolf EJ; McGlinchey RE; Milberg WP; Stone A; Schichman SA; Miller MW
Brain; 2017 Mar; 140(3):813-825. PubMed ID: 28077398
[TBL] [Abstract][Full Text] [Related]
18. Hippocampal and Clinical Trajectories of Mild Cognitive Impairment with Suspected Non-Alzheimer's Disease Pathology.
Chung JK; Plitman E; Nakajima S; Caravaggio F; Iwata Y; Gerretsen P; Kim J; Takeuchi H; Shinagawa S; Patel R; Chakravarty MM; Graff-Guerrero A;
J Alzheimers Dis; 2017; 58(3):747-762. PubMed ID: 28505977
[TBL] [Abstract][Full Text] [Related]
19. Dynamic predictions in Bayesian functional joint models for longitudinal and time-to-event data: An application to Alzheimer's disease.
Li K; Luo S
Stat Methods Med Res; 2019 Feb; 28(2):327-342. PubMed ID: 28750578
[TBL] [Abstract][Full Text] [Related]
20. The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment.
Ba M; Ng KP; Gao X; Kong M; Guan L; Yu L;
Eur J Neurol; 2019 May; 26(5):733-e53. PubMed ID: 30561868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
